Handbook of Clinical Gender Medicine. Группа авторов

Certain sex-linked traits may play a role; for example, the uVNTR polymorphism of the MAOA gene on the X chromosome has been found to confer vulnerability to depression more in women than in men [15]. Similarly, estrogen receptor-beta (ER-β) appears to play a role in anxiety: Krezel et al. [16] reported an increase in anxiety-related behaviors in ER-β knockout female mice but not in males.

      Gonadal Steroids

      The increased rate of depression in women during puberty, when gonadal hormone systems are activated, suggests that hormones may contribute to sex differences in depression. Research linking affective disturbances in women with periods of hormonal change – particularly during the premenstrual and postpartum periods – further reinforces this hypothesis.

It has long been debated whether the postpartum period is a time of increased risk for mood disorders, because the overall prevalence of depression does not appear to be higher in women after delivery compared with age-matched comparison women. Epidemiological studies have estimated the 12-month prevalence rate of major depressive disorder in women of childbearing age to be 12% [2], and a meta-analysis of 59 studies of postpartum depression (PPD) estimated a similar prevalence rate of 13% [17]. However, serious depression requiring admission to the hospital is clearly more prevalent following childbirth; Kendell et al. [18] found that the relative risk of psychiatric admission was extremely high during the first 30 days after childbirth and remained higher than it was before pregnancy for at least 2 years after giving birth. A Danish study compared the rates of hospital admissions or outpatient visits for mental disorders of more than 2 million adults and found that new mothers had a higher risk of depressive disorders during the first 5 months after giving birth [19].

Studies have failed to find consistent hormonal differences in women with and without PPD, leading researchers to hypothesize that the typical hormonal changes during the postpartum period may directly increase the risk of depression but only in some women. A study by Bloch et al. [20] used leuprolide in conjunction with high-dose estradiol and progesterone to create a scaled-down model of pregnancy and the puerperium. Using this model, investigators demonstrated that high-dose hormone add-back followed by abrupt withdrawal elicited dramatic depressive symptoms in euthymic women with a history of PPD. No mood symptoms were evident in women lacking that history. This study demonstrated that, despite the absence of consistent evidence of abnormal hormonal levels in women with PPD, gonadal steroids were nonetheless directly involved in triggering the depressive episodes in a susceptible population.

      The hormonal changes throughout the menstrual cycle have also been implicated in affective dysregulation in women. Although many women report mild-to-moderate physical or emotional symptoms during the late luteal phase of their menstrual cycle, approximately 5–10% experience significant mood disturbances in the days prior to menses. This condition, known as premenstrual dysphoric disorder, like PPD, represents a differential affective response to normal fluctuations in steroid levels in a susceptible population. Although the source of this susceptibility is unknown, controlled, double-blind studies manipulating gonadal steroid levels have clearly demonstrated a role of estradiol and progesterone in a subset of depressions in women – those related to reproductive events – thus suggesting a possible sex-dependent source of variance in the etiopathogenesis of depression.

      Integrated Model of Depression

No single factor can explain the sex difference in depression; rather, it is likely the result of complex interactions between biological and environmental factors. As research has shown, the impact of sex differences may be elicited only in certain environmental contexts. For example, Curley et al. [21] demonstrated that maternal cues early in life can impact behavioral development in offspring. Impaired maternal care (e.g. decreased licking and grooming of pups) led to increased neophobia and decreased exploratory behavior in female offspring only [21]. Researchers demonstrated that this was not due to inheritance of a genetic mutation but instead was due to an epigenetic modification. Moreover, transgenerational effects were also observed: The female offspring went on to display impaired maternal care as well, and their own female pups also displayed neophobic phenotypes. Mueller and Bale [22] examined the behavior of mice exposed to stress during gestation and found that early prenatal stress contributed to a stress-sensitive phenotype in male mice only. These studies illustrate that sex-specific programming begins very early in life and may contribute to the vulnerability to environmental stressors; additionally they provide key insight into the underlying programming of sex-biased neurodevelopmental disorders such as depression.

      References

1 Weissman MM, Bland RC, Canino GJ, et al: Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996;276:293–299.

2 Kessler RC, McGonagle KA, Swart M, Blazer DG, Nelson CB: Sex and depression in the national comorbidity survey. 1. Lifetime prevalence, chronicity and recurrence. J Affect Disord 1993;29:85–96.

3 Rubinow DR, Moore M: Sex-dependent modulation of treatment response. Dialoques Clin Neurosci 2004;6:39–51.

4 Hamilton JA, Grant M, Jensvold MF: Sex and treatment of depression; in Jensvold MF, Halbreich U, Hamilton JA (eds): Psychopharmacology and Women: Sex, Gender, and Hormones. Washington, American Psychiatric Association Press, 1996, pp 241–260.

5 Kornstein SC, Schatzberg AF, Thase ME, et al: Gender differences in treatment response to sertra-line versus imipramine in chronic depression. Am J Psychiatry 2000;157:1445–1452.

6 Parker G, Parker K, Austin MP, Mitchell P, Brotchie H: Gender differences in response to differing antidepressant drug classes: two negative studies. Psychol Med 2003;33:1473–1477.

7 Quitkin FM, Stewart JW, McGrath PJ, et al: Are there differences between women’s and men’s antidepressant responses? Am J Psychiatry 2002;159:1848–1854.

8 Raznahan A, Lee Y, Stidd R, et al: Longitudinally mapping the influence of sex and androgen signaling on the dynamics of human cortical maturation in adolescence. Proc Natl Acad Sci USA 2010;107:16988–16993.

9 Kilpatrick LA, Zald DH, et al: Sex-related differences in amygdala functional connectivity during resting conditions. Neuroimage 2006;30:452–461.

10 Protopopescu X, Pan H, Altemus M, Tuescher O, Polanecsky M, McEwen B, Silbersweig D, Stern E: Orbitofrontal cortex activity related to emotional processing changes across the menstrual cycle. Proc Natl Acad Sci USA 2005;102:16060–16065.